Reviews on Clinical Pharmacology and Drug Therapy,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 28, 2024
Background:
Luteinizing
hormone
(LH)
and
human
chorionic
gonadotropin
(hCG)
preparations
are
widely
used
in
medicine
to
correct
reproductive
disorders,
but
characterized
by
many
side
effects.
In
this
regard,
low-molecular-weight
allosteric
agonists
of
the
LH
receptor
(LHR)
being
developed,
most
active
which
thieno[2,3-d]-pyrimidine
derivatives
(TPs).
Aim:
To
study
stimulating
effects
compound
TP03,
developed
us,
on
activity
membrane-bound
adenylate
cyclase
(AC)
vitro
testicular
ovarian
steroidogenesis
vivo
comparison
with
those
Org43553,
“gold”
standard
LHR
agonists.
Materials
methods:
The
TP03
Org43553
(10-8–10-3
M)
basal
hCG-stimulated
(10-9
AC
membrane
fractions
isolated
from
rat
testes
ovaries
were
assessed
using
[α-32P]-ATP.
(in
two
doses
–
10
20
mg/kg,
i.p.)
blood
testosterone
levels
male
rats
progesterone
immature
female
pre-stimulated
Follimag®
vivo,
as
well
effect
co-administration
or
(10
hCG
IU/rat,
s.c.)
rats.
Testosterone
determined
enzyme
immunoassay.
Results:
Compound
was
comparable
its
ability
stimulate
membranes.
When
administered
rats,
dose-dependently
stimulated
production,
when
it
increased
their
levels,
not
inferior
these
parameters.
relatively
low
together
additivity
observed,
more
pronounced
than
case
a
combination
hCG.
Conclusions:
we
is
along
this,
demonstrates
hCG,
indicates
prospects
for
use
increase
effectiveness
therapy.
Российский физиологический журнал им И М Сеченова,
Journal Year:
2024,
Volume and Issue:
110(6), P. 976 - 993
Published: Oct. 20, 2024
The
search
for
natural
biologically
active
substances
that
have
a
neuroprotective
effect
on
cerebral
ischemia-reperfusion
is
one
of
the
urgent
problems
modern
neuroscience
and
medicine.
Intranasally
administered
insulin
(IAI)
has
pronounced
restorative
various
neurodegenerative
diseases,
but
mechanisms
its
action
therapeutic
effects
in
ischemia
not
been
studied
well,
including
type
2
diabetes
mellitus
(DM2),
which
increases
risk
cerebrovascular
dysfunction.
aim
work
was
to
study
IAI
metabolic
parameters
inflammatory
factors
male
rats
with
DM2
subjected
two-vessel
prolonged
forebrain
reperfusion,
comparison
non-diabetic
animals.
A
long-term
high-fat
diet
an
injection
low
dose
streptozotocin
(25
mg/kg)
used
induce
DM2,
model
global
induced
by
occlusion
both
common
carotids
reperfusion
(IR)
7
days
ischemia.
Two
hours
after
end
ischemia,
were
treated
at
0.5
or
2.0
IU/rat,
drug
same
doses
daily
subsequent
days.
It
found
prevents
body
weight
loss
nondiabetic
diabetic
underwent
IR,
also
total
cholesterol
level
proportion
epididymal
fat
without
IR.
In
explored
reduces
postprandial
glucose
content
blood,
indicates
improvement
tolerance,
levels
blood
–
C-reactive
protein
(at
IU/rat/day)
tumor
necrosis
factor-α
(in
IU/rat/day),
reveals
anti-inflammatory
potential.
Thus,
course
treatment
induction
followed
leads
weakens
reactions
may
be
demand
correction
ischemic
stroke
patients
DM2.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(20), P. 11328 - 11328
Published: Oct. 21, 2024
Several
reports,
including
our
previous
studies,
indicate
that
hyperglycemia
and
diabetes
mellitus
exert
differential
effects
on
vascular
function
in
males
females.
This
study
examines
sex
differences
the
of
type
2
(T2D)
an
established
monogenic
model
obesity-induced
T2D,
Zucker
Diabetic
Fatty
(ZDF)
rats.
Acetylcholine
(ACh)
responses
were
assessed
phenylephrine
pre-contracted
rings
before
after
apocynin,
a
NADPH
oxidase
(NOX)
inhibitor.
The
mRNA
expressions
aortic
endothelial
NOS
(eNOS),
key
NOX
isoforms
also
measured.
We
demonstrated
following:
(1)
had
contrasting
vasorelaxation
ZDF
rats,
impairing
relaxation
to
ACh
females
while
enhancing
it
male
rats;
(2)
inhibition
NOX,
major
source
superoxide
vasculature,
restored
female
(3)
eNOS
NOX4
elevated
(but
not
male)
rat
aortas
compared
their
respective
leans.
highlights
sexual
dimorphism
ACh-mediated
aorta
suggesting
may
play
role
impaired
observed
Успехи физиологических наук,
Journal Year:
2024,
Volume and Issue:
55(4), P. 45 - 74
Published: Dec. 8, 2024
The
regulatory
effects
of
luteinizing
hormone
(LH)
and
chorionic
gonadotropin
(CG)
are
realized
through
the
activation
G-protein
coupled
LH/CG
receptor
(LH/CG-R).
result
this
is
various
types
G
proteins,
which
leads
to
stimulation
(Gs)
or
inhibition
(Gi)
cAMP-dependent
pathway
calcium
signaling
(Gq/11,
Gi),
recruitment
β-arrestins,
prevent
protein
internalization
downregulation,
but
can
also
activate
mitogen-activated
kinase
cascade.
Despite
a
certain
similarity
in
LH
CG,
there
differences
between
them
both
efficiency
pattern
regulation
LH/CG-R.
This
consequence
affinity
CG
orthosteric
site
receptor,
as
well
at
level
allosteric
due
presence
C-terminal
extension
β-subunit
including
sites
for
O-glycosylation,
variability
N-glycosylation
α-
β-subunits
gonadotropins.
Moreover,
number
N-glycans,
degree
their
branching
charge
differ,
different
intracellular
cascades,
affecting
physiological
response
reproductive
system
Of
great
importance
formation
homodi(oligo)meric
complexes
LH/CG-R
its
heterocomplexes
with
follicle-stimulating
where
protomers
allosterically
influence
bias
signal
transduction.
Taking
into
account
large
LH/CG-R,
development
low-molecular
regulators
underway,
agonists
based
on
thieno[2,3-d]-pyrimidine
peptides
derived
from
cytoplasmic
loops
These
become
prototypes
drugs
correcting
functions
system.
review
devoted
analysis
data
similarities
gonadotropins
activity,
role
mechanisms
this,
prospects
creating
Reviews on Clinical Pharmacology and Drug Therapy,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 28, 2024
Background:
Luteinizing
hormone
(LH)
and
human
chorionic
gonadotropin
(hCG)
preparations
are
widely
used
in
medicine
to
correct
reproductive
disorders,
but
characterized
by
many
side
effects.
In
this
regard,
low-molecular-weight
allosteric
agonists
of
the
LH
receptor
(LHR)
being
developed,
most
active
which
thieno[2,3-d]-pyrimidine
derivatives
(TPs).
Aim:
To
study
stimulating
effects
compound
TP03,
developed
us,
on
activity
membrane-bound
adenylate
cyclase
(AC)
vitro
testicular
ovarian
steroidogenesis
vivo
comparison
with
those
Org43553,
“gold”
standard
LHR
agonists.
Materials
methods:
The
TP03
Org43553
(10-8–10-3
M)
basal
hCG-stimulated
(10-9
AC
membrane
fractions
isolated
from
rat
testes
ovaries
were
assessed
using
[α-32P]-ATP.
(in
two
doses
–
10
20
mg/kg,
i.p.)
blood
testosterone
levels
male
rats
progesterone
immature
female
pre-stimulated
Follimag®
vivo,
as
well
effect
co-administration
or
(10
hCG
IU/rat,
s.c.)
rats.
Testosterone
determined
enzyme
immunoassay.
Results:
Compound
was
comparable
its
ability
stimulate
membranes.
When
administered
rats,
dose-dependently
stimulated
production,
when
it
increased
their
levels,
not
inferior
these
parameters.
relatively
low
together
additivity
observed,
more
pronounced
than
case
a
combination
hCG.
Conclusions:
we
is
along
this,
demonstrates
hCG,
indicates
prospects
for
use
increase
effectiveness
therapy.